LTIP Awards

Hikma Pharmaceuticals Plc
30 April 2008


                    Hikma Pharmaceuticals PLC - LTIP Awards


LONDON, 30 April 2008: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)
announces that the Remuneration Committee has made the following nil-cost awards
under the Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan (the 'LTIP')
to Directors and Persons Discharging Managerial Responsibility ('PDMRs') of the
Company.

Awards under the LTIP were made on 29 April 2008 at a price of £4.64 per
ordinary share as follows:-

Name of Director/PDMR Number of LTIP Shares
Said Darwazah 90,000
Mazen Darwazah 54,000
Bassam Kanaan 54,000
Taghreed Al-Shunnar 54,000
Majda Labadi 54,000
Nabil Rizk 54,000

The shares subject to the LTIP awards will only be released to the participants
in three years time, subject to their continued employment and the satisfaction
of the comparative Total Shareholder Return ('TSR') performance target.
Participants will only receive the full benefit of their share incentives if TSR
performance against the Comparator Group is at least at the upper quartile.

                                    - ENDS -
Enquiries:

Hikma Pharmaceuticals PLC
Henry Knowles                                     [phone]
Company Secretary

Susan Ringdal                                     [phone]
Investor Relations Director

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products.  Hikma's operations
are conducted through three businesses: 'Branded', 'Injectables' and
'Generics'.  Hikma's operations are based principally in the Middle East and
North Africa ('MENA') region, where it is a market leader and sells across 17
countries, the United States and Europe.  In 2007, the Group achieved revenues
of $449 million (2006 $317 million) and profit attributable to shareholders was
$63 million (2006 $55 million).  For news and other information, please visit
www.hikma.com.



                      This information is provided by RNS
            The company news service from the London Stock Exchange